Last reviewed · How we verify
NCT04319016: COVID-preg
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy
trial testing pregnant women with laboratory-confirmed 2019-n-CoV in Infection Viral in 200 participants. Status unknown.
30 April 2020
Quick facts
| Lead sponsor | Federico II University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 January 2020 |
| Primary completion | 30 April 2020 |
| Estimated completion | 1 May 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- pregnant women with laboratory-confirmed 2019-n-CoV
Conditions studied
- Infection Viral — all drugs for Infection Viral →
Sponsor
Federico II University
Who can join
Eligibility, female only, with Infection Viral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Novel Coronavirus (2019-nCoV), also known as Wuhan coronavirus, causes the 2019-nCoV acute respiratory disease.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19.
Ferraiolo A, Barra F, Kratochwila C, Paudice M, et al · · 2020 · cited 51× · PMID 32580461 · DOI 10.3390/medicina56060306 -
A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19-A Call for Clinical Trials.
Pastick KA, Nicol MR, Smyth E, Zash R, et al · · 2020 · cited 21× · PMID 32929403 · DOI 10.1093/ofid/ofaa350
Verify or expand the search:
- PubMed search for NCT04319016
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pregnant women with laboratory-confirmed 2019-n-CoV
Trials testing the same drug.
- NCT04315870 — Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pre · unknown
Other recruiting trials for Infection Viral
Currently open trials in the same condition.
- NCT07110636 — Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients · NA · recruiting
- NCT06286657 — Xanthohumol and Viral Infections (XL) · NA · recruiting
- NCT06178822 — Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room · recruiting
- NCT03818334 — Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies · Phase 2, PHASE3 · recruiting
Other Federico II University trials
Trials by the same sponsor.
- NCT07437690 — Fall Prevention in Older Adults in an Italian Cohort · not yet recruiting
- NCT07282132 — Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter · not yet recruiting
- NCT07280286 — Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel · NA · not yet recruiting
- NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy · recruiting
- NCT07314684 — GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04319016 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federico II University
- Last refreshed: 28 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04319016.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing